Granite Point Capital Management, L.P. - TETRAPHASE PHARMACEUTICALS I ownership

Back to all holdings Add to watchlist

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 107 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2015$3,568,000
+22.9%
75,206
-5.1%
1.04%
-2.4%
Q1 2015$2,904,000
+108.9%
79,250
+126.4%
1.06%
+63.0%
Q4 2014$1,390,000
+74.2%
35,000
-12.5%
0.65%
+64.2%
Q3 2014$798,000–40,000–0.40%–
 Download
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2015
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders